RePark: Development of a Parkinson disease (PD) in vitro model to study the efficacy of therapeutic biomolecules to cross the BBB and revert PD hallmarks.

Joined March 2023
📢 new paper alert 🚨🚨 Our recent paper about "Cooling rate uncovers epimer-dependent supramolecular organization of carbohydrate amphiphiles" published in the @JMaterChem B @AlexandraMBrito @RLGReis @iva_pashkuleva @RicardoAPires @3bsuminho 👇doi.org/10.1039/D4TB00728J
1
4
12
356
🗣️Today is World Parkinson’s Day, marking the second most common neurological disorder affecting movement and coordination. The Repark Project by @3bsuminho, @TAUMedFaculty, @LabAdler and @UAntwerpen aims to develop a 3D in vitro PD model to test new therapeutic drugs. #PDday🧠
5
5
182
A very special day with the official opening of our new infrastructure, TERM Research Hub/City of Guimarães Institute! It took almost 10 years to achieve this major milestone but we are very proud of the final outcome! @RLGReis @3bsuminho @UMinho_Oficial @municipiogmr
1
6
14
1,019